121 related articles for article (PubMed ID: 8578930)
1. Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.
Miklós S
Acta Biomed Ateneo Parmense; 1995; 66(3-4):139-46. PubMed ID: 8578930
[TBL] [Abstract][Full Text] [Related]
2. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
3. The effect of circulating androgens on bone mineral density in postmenopausal women.
Tok EC; Ertunc D; Oz U; Camdeviren H; Ozdemir G; Dilek S
Maturitas; 2004 Jul; 48(3):235-42. PubMed ID: 15207889
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone sulphate and bone mineral density.
Szathmári M; Szũcs J; Fehér T; Holló I
Osteoporos Int; 1994 Mar; 4(2):84-8. PubMed ID: 8003845
[TBL] [Abstract][Full Text] [Related]
5. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women.
Haden ST; Glowacki J; Hurwitz S; Rosen C; LeBoff MS
Calcif Tissue Int; 2000 Jun; 66(6):414-8. PubMed ID: 10821876
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women.
Barrett-Connor E; Kritz-Silverstein D; Edelstein SL
Am J Epidemiol; 1993 Jan; 137(2):201-6. PubMed ID: 8452124
[TBL] [Abstract][Full Text] [Related]
7. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
8. [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].
Bácsi K; Kósa J; Lazáry A; Balla B; Horváth H; Takács I; Nagy Z; Speer G; Lakatos P
Orv Hetil; 2007 Jul; 148(27):1273-80. PubMed ID: 17604264
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
Sambrook P; Birmingham J; Champion D; Kelly P; Kempler S; Freund J; Eisman J
J Rheumatol; 1992 Mar; 19(3):357-61. PubMed ID: 1533677
[TBL] [Abstract][Full Text] [Related]
10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
Földes J; Lakatos P; Zsadányi J; Horváth C
Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
[TBL] [Abstract][Full Text] [Related]
12. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
13. The relationship between sex steroids and bone mineral content in women soon after the menopause.
Spector TD; Thompson PW; Perry LA; McGarrigle HH; Edwards AC
Clin Endocrinol (Oxf); 1991 Jan; 34(1):37-41. PubMed ID: 1825938
[TBL] [Abstract][Full Text] [Related]
14. [Reduced serum dehydroepiandrosterone levels in postmenopausal osteoporosis].
Fingerová H; Matlochová J
Ceska Gynekol; 1998 Apr; 63(2):110-3. PubMed ID: 9650403
[TBL] [Abstract][Full Text] [Related]
15. [Androgens and bone metabolism].
Szathmári M; Holló I
Dtsch Med Wochenschr; 1993 Feb; 118(6):204-5. PubMed ID: 8436072
[No Abstract] [Full Text] [Related]
16. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
Frost ML; Fogelman I; Blake GM; Marsden PK; Cook G
J Bone Miner Res; 2004 Nov; 19(11):1797-804. PubMed ID: 15476579
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis in mixed connective tissue disease.
Bodolay E; Bettembuk P; Balogh A; Szekanecz Z
Clin Rheumatol; 2003 Sep; 22(3):213-7. PubMed ID: 14505213
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
Zofkova I; Hill M
Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
[TBL] [Abstract][Full Text] [Related]
19. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
[TBL] [Abstract][Full Text] [Related]
20. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
